hall 8a, booth F35.1
Surfix BV presents its advanced nanocoatings for the micro- and nanotechnology market. Surfix’s proprietary surface modification technology can be used to locally functionalize complex devices with molecular nanocoatings. With relative ease micropatterns of e.g. hydrophilic and hydrophobic or protein-binding and protein-repellent areas can be generated on various inorganic and polymeric surfaces as well as in microfluidic channels. Does this sound interesting to you? Then please visit us and let us show you how your device can benefit from Surfix’s advanced surface modification.Surfix’s mission is to advance global health by delivering accurate, accessible, and affordable diagnostic solutions for disease detection and management, specifically in underserved Point-of-Care (POC) testing segments.
To achieve this goal, Surfix has developed a photonic diagnostics platform that delivers exceptional sensitivity, accuracy, and a broad dynamic range. This cutting-edge technology enables diagnostics with precision surpassing traditional laboratory standards – a POCT with beyond lab-level precision.
Surfix’s objective is to continuously enhance the platform, ensuring it remains easy to use while offering reliable and sensitive detection of a wide array of biomarkers. By doing so, Surfix is committed to elevating healthcare standards and making advanced diagnostics accessible globally.